Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
Revenue Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
18.32%
↑ 300% above average
Average (29q)
4.58%
Historical baseline
Range
High:219.18%
Low:-100.00%
Volatility
6964.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 18.32% |
| Q2 2025 | 219.18% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |
| Q3 2022 | 0.00% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2005 | 0.00% |
| Q3 2005 | 0.00% |
| Q2 2005 | 0.00% |
| Q1 2005 | 0.00% |
| Q4 2004 | 0.00% |
| Q3 2004 | 0.00% |